These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3159025)

  • 1. Comparative pharmacology of cyclooxygenase inhibitors on platelet function.
    Rao GH; White JG
    Prostaglandins Leukot Med; 1985 Apr; 18(1):119-31. PubMed ID: 3159025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function.
    Rao GH; Radha E; White JG
    Biochem Biophys Res Commun; 1983 Dec; 117(2):549-55. PubMed ID: 6229254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin.
    Rao GH; Johnson GG; Reddy KR; White JG
    Arteriosclerosis; 1983; 3(4):383-8. PubMed ID: 6411052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function.
    Rao GH; Cox AC; Gerrard JM; White JG
    Biochim Biophys Acta; 1980 Apr; 628(4):468-79. PubMed ID: 7370301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible platelet aggregation does not depend on lipoxygenase metabolites.
    Rao GH; Radha E; White JG
    Biochem Biophys Res Commun; 1985 Aug; 131(1):50-7. PubMed ID: 3929780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
    Raz A
    Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation.
    Rao GH; White JG
    Am J Hematol; 1985 Aug; 19(4):339-47. PubMed ID: 3161324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsaturated fatty acids inhibit ADP- arachidonate-induced platelet aggregation without affecting thromboxane synthesis.
    Dratewka-Kos E; Tinker DO; Kindl B
    Biochem Cell Biol; 1986 Sep; 64(9):906-13. PubMed ID: 3778664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of 12-HETE production in human platelets by an immunomodulator, LF 1695. Evidence for activation of arachidonate liberation coupled to cyclo-oxygenase inhibition.
    Hullin F; Ragab-Thomas JM; Sepulchre C; Pascal M; Chap H; Douste-Blazy L
    Biochem Pharmacol; 1989 Sep; 38(17):2763-72. PubMed ID: 2505775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docosahexaenoic acid (C22:6 omega 3) and linoleic acid are anti-aggregatory, and alter arachidonic acid metabolism in human platelets.
    Srivastava KC
    Prostaglandins Leukot Med; 1985 Mar; 17(3):319-27. PubMed ID: 3158002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity.
    Barradas MA; Jeremy JY; Kontoghiorghes GJ; Mikhailidis DP; Hoffbrand AV; Dandona P
    FEBS Lett; 1989 Mar; 245(1-2):105-9. PubMed ID: 2494068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function.
    Roy J; Adili R; Kulmacz R; Holinstat M; Das A
    J Pharmacol Exp Ther; 2016 Oct; 359(1):134-41. PubMed ID: 27488919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miconazole inhibition of platelet aggregation by inhibiting cyclooxygenase.
    Ishikawa S; Manabe S; Wada O
    Biochem Pharmacol; 1986 Jun; 35(11):1787-92. PubMed ID: 3087363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of antioxidants on arachidonic acid metabolism and platelet function.
    Rao GH; Tate MR; Murthy M; Hebbel RP; White JG
    Biochem Med Metab Biol; 1994 Feb; 51(1):74-9. PubMed ID: 8192920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.